Fluid biomarkers in Alzheimer's disease
Authors:
- Joel SimrénJSJoel Simrén
- Henrik ZetterbergHZHenrik Zetterberg
- 4 November 2022
- book chapter
- Published by Elsevier
- Vol. 112, 249-281
Abstract
No abstract availableKeywords
This publication has 164 references indexed in Scilit:
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010Journal of Neuropathology & Experimental Neurology, 2012
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's DiseaseBiological Psychiatry, 2010
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrationsNature Biotechnology, 2010
- The clinical use of structural MRI in Alzheimer diseaseNature Reviews Neurology, 2010
- TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisArchives of Neurology, 2008
- Alzheimer's diseaseThe Lancet, 2006
- Astrocyte activation and reactive gliosisGlia, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 alleleJournal of Neural Transmission, 1996
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991